TruBridge TBRG shares soared 5.6% in the last trading session to close at $20.43. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 7.4% loss over the past four weeks.
TruBridge recorded a strong price rise on investors’ optimism surrounding its recent achievement of being ranked as among Modern Healthcare’s 2025 Best in Business.The award reflects the company’s commitment to rural and community healthcare, aiming to help providers recoup revenue, reduce denials and strengthen fiscal sustainability. TruBridge had reached several key milestones in 2025 that led to this recognition.
This healthcare information technology company is expected to post quarterly earnings of $0.41 per share in its upcoming report, which represents a year-over-year change of +720%. Revenues are expected to be $87.63 million, up 0.3% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For TruBridge, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TBRG going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
TruBridge is part of the Zacks Medical Info Systems industry. Schrodinger, Inc. SDGR, another stock in the same industry, closed the last trading session 0.9% higher at $14.09. SDGR has returned -22.3% in the past month.
Schrodinger's consensus EPS estimate for the upcoming report has changed +2.4% over the past month to -$0.13. Compared to the company's year-ago EPS, this represents a change of +76.4%. Schrodinger currently boasts a Zacks Rank of #4 (Sell).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
TruBridge, Inc. (TBRG): Free Stock Analysis Report Schrodinger, Inc. (SDGR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
